US Stock MarketDetailed Quotes

Jasper Therapeutics (JSPR)

Watchlist
  • 0.8384
  • -0.0667-7.37%
Close Apr 24 16:00 ET
  • 0.8200
  • -0.0184-2.19%
Post 19:49 ET
23.47MMarket Cap-0.21P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jasper Therapeutics (JSPR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
10.03%83.88M
-37.36%15.84M
-3.64%19.17M
69.30%27.08M
44.65%21.8M
10.71%76.24M
42.65%25.29M
2.72%19.89M
-10.29%15.99M
8.07%15.07M
Selling and administrative expenses
1.77%20.78M
-18.76%4.48M
-12.13%4.78M
25.19%5.88M
18.24%5.65M
19.57%20.42M
41.72%5.51M
20.38%5.43M
3.69%4.7M
15.26%4.77M
-General and administrative expense
1.77%20.78M
-18.76%4.48M
-12.13%4.78M
25.19%5.88M
18.24%5.65M
19.57%20.42M
41.72%5.51M
20.38%5.43M
3.69%4.7M
15.26%4.77M
Research and development costs
13.05%63.1M
-42.55%11.36M
-0.44%14.39M
87.64%21.2M
56.89%16.16M
7.79%55.82M
42.91%19.77M
-2.65%14.46M
-15.05%11.3M
5.03%10.3M
Operating profit
-10.03%-83.88M
37.36%-15.84M
3.64%-19.17M
-69.30%-27.08M
-44.65%-21.8M
-10.71%-76.24M
-42.65%-25.29M
-2.72%-19.89M
10.29%-15.99M
-8.07%-15.07M
Net non-operating interest income expense
-65.58%1.74M
-63.97%338K
-73.36%342K
-69.86%437K
-54.98%624K
-2.71%5.06M
-23.99%938K
-10.40%1.28M
0.97%1.45M
26.46%1.39M
Non-operating interest income
-65.58%1.74M
-63.97%338K
-73.36%342K
-69.86%437K
-54.98%624K
-2.71%5.06M
-23.99%938K
-10.40%1.28M
0.97%1.45M
26.46%1.39M
Other net income (expense)
7,305.68%6.34M
24,515.38%6.4M
375.00%88K
-110.00%-84K
-50.00%-63K
89.04%-88K
128.89%26K
-108.31%-32K
-112.86%-40K
97.02%-42K
Gain on sale of security
--8.53M
--6.43M
--2.1M
----
----
----
----
----
----
----
Special income (charges)
----
----
----
----
----
--0
--0
-94.01%20K
--0
97.38%-20K
-Less：Restructuring and merger&acquisition
----
----
----
----
----
--0
--0
94.01%-20K
--0
-97.38%20K
Other non- operating income (expenses)
-2,385.23%-2.19M
-211.54%-29K
-6,184.38%-2.01M
-110.00%-84K
-50.00%-63K
64.23%-88K
122.03%26K
-162.75%-32K
63.30%-40K
40.00%-42K
Income before tax
-6.36%-75.8M
62.58%-9.1M
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
Income tax
Net income
-6.36%-75.8M
62.58%-9.1M
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
Net income continuous Operations
-6.36%-75.8M
62.58%-9.1M
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
Minority interest income
Net income attributable to the parent company
-6.36%-75.8M
62.58%-9.1M
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.36%-75.8M
62.58%-9.1M
-0.53%-18.74M
-83.25%-26.72M
-54.73%-21.24M
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
Basic earnings per share
19.22%-3.95
80.25%-0.32
8.87%-1.13
-79.38%-1.74
-36.89%-1.41
20.87%-4.89
-8.00%-1.62
22.50%-1.24
34.01%-0.97
36.42%-1.03
Diluted earnings per share
19.22%-3.95
80.25%-0.32
8.87%-1.13
-79.38%-1.74
-36.89%-1.41
20.87%-4.89
-8.00%-1.62
22.50%-1.24
34.01%-0.97
36.42%-1.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 10.03%83.88M-37.36%15.84M-3.64%19.17M69.30%27.08M44.65%21.8M10.71%76.24M42.65%25.29M2.72%19.89M-10.29%15.99M8.07%15.07M
Selling and administrative expenses 1.77%20.78M-18.76%4.48M-12.13%4.78M25.19%5.88M18.24%5.65M19.57%20.42M41.72%5.51M20.38%5.43M3.69%4.7M15.26%4.77M
-General and administrative expense 1.77%20.78M-18.76%4.48M-12.13%4.78M25.19%5.88M18.24%5.65M19.57%20.42M41.72%5.51M20.38%5.43M3.69%4.7M15.26%4.77M
Research and development costs 13.05%63.1M-42.55%11.36M-0.44%14.39M87.64%21.2M56.89%16.16M7.79%55.82M42.91%19.77M-2.65%14.46M-15.05%11.3M5.03%10.3M
Operating profit -10.03%-83.88M37.36%-15.84M3.64%-19.17M-69.30%-27.08M-44.65%-21.8M-10.71%-76.24M-42.65%-25.29M-2.72%-19.89M10.29%-15.99M-8.07%-15.07M
Net non-operating interest income expense -65.58%1.74M-63.97%338K-73.36%342K-69.86%437K-54.98%624K-2.71%5.06M-23.99%938K-10.40%1.28M0.97%1.45M26.46%1.39M
Non-operating interest income -65.58%1.74M-63.97%338K-73.36%342K-69.86%437K-54.98%624K-2.71%5.06M-23.99%938K-10.40%1.28M0.97%1.45M26.46%1.39M
Other net income (expense) 7,305.68%6.34M24,515.38%6.4M375.00%88K-110.00%-84K-50.00%-63K89.04%-88K128.89%26K-108.31%-32K-112.86%-40K97.02%-42K
Gain on sale of security --8.53M--6.43M--2.1M----------------------------
Special income (charges) ----------------------0--0-94.01%20K--097.38%-20K
-Less：Restructuring and merger&acquisition ----------------------0--094.01%-20K--0-97.38%20K
Other non- operating income (expenses) -2,385.23%-2.19M-211.54%-29K-6,184.38%-2.01M-110.00%-84K-50.00%-63K64.23%-88K122.03%26K-162.75%-32K63.30%-40K40.00%-42K
Income before tax -6.36%-75.8M62.58%-9.1M-0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M
Income tax
Net income -6.36%-75.8M62.58%-9.1M-0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M
Net income continuous Operations -6.36%-75.8M62.58%-9.1M-0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M
Minority interest income
Net income attributable to the parent company -6.36%-75.8M62.58%-9.1M-0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.36%-75.8M62.58%-9.1M-0.53%-18.74M-83.25%-26.72M-54.73%-21.24M-10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M
Basic earnings per share 19.22%-3.9580.25%-0.328.87%-1.13-79.38%-1.74-36.89%-1.4120.87%-4.89-8.00%-1.6222.50%-1.2434.01%-0.9736.42%-1.03
Diluted earnings per share 19.22%-3.9580.25%-0.328.87%-1.13-79.38%-1.74-36.89%-1.4120.87%-4.89-8.00%-1.6222.50%-1.2434.01%-0.9736.42%-1.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -